Silydianin

Silydianin is a flavonolignan compound found in milk thistle that functions as part of the silymarin complex. It demonstrates antioxidant activity by reducing reactive oxygen species production and shows potential antiviral properties.

Origin & History

Silydianin is a flavonolignan compound isolated from the seeds of Silybum marianum (milk thistle), a plant native to the Mediterranean region. It forms part of the silymarin complex alongside silybin and silychristin, typically extracted via solvent methods from the plant's fruits or seeds.

Historical & Cultural Context

While no direct historical data exists on isolated silydianin, Silybum marianum (milk thistle) seeds have been used in traditional European herbal medicine for liver disorders since ancient times. The silymarin complex was popularized in the 20th century for hepatoprotection.

Health Benefits

• May support liver health as part of silymarin complex, though a 48-week RCT (n=78) showed no significant histological improvement in NASH patients (PMID:31536511)
• Demonstrates antioxidant properties by reducing reactive oxygen species production in vitro studies
• Shows antiviral activity against enteroviruses including coxsackie B2, poliovirus, and EV71 with up to 100% inhibition at 400 µg/mL in cell studies
• May improve metabolic parameters in type 2 diabetes when taken as part of silymarin (200mg t.i.d. improved glucose and HbA1c, PMID:17072885)
• Could support gastric motility and metabolic syndrome management based on in vivo studies at 200mg/kg

How It Works

Silydianin acts as an antioxidant by scavenging reactive oxygen species and reducing oxidative stress in hepatocytes. The compound modulates cellular antioxidant enzyme systems and may interfere with viral replication through inhibition of viral RNA synthesis. It works synergistically with other silymarin components including silybin and silychristin to enhance hepatoprotective effects.

Scientific Research

Clinical evidence primarily evaluates silymarin complex rather than isolated silydianin. A phase II RCT (PMID:31536511) testing silymarin in NASH patients found no significant histological improvement, while a meta-analysis (PMID:30477860) showed silymarin improved metabolic status in T2DM. A 4-month RCT (PMID:17072885) demonstrated improvements in fasting glucose and HbA1c with 600mg/day silymarin.

Clinical Summary

Limited clinical research exists specifically on silydianin as an isolated compound. A 48-week randomized controlled trial (n=78) examining silymarin complex containing silydianin showed no significant histological improvement in NASH patients. Most evidence comes from in vitro studies demonstrating antioxidant and antiviral activities. The clinical efficacy of silydianin alone remains poorly established compared to the broader silymarin complex.

Nutritional Profile

Silydianin is a pure flavonolignan compound (C₂₅H₂₂O₁₀, molecular weight ~482.44 g/mol), not a food ingredient, and therefore carries no conventional macronutrient or micronutrient profile (zero protein, fat, carbohydrate, fiber, or caloric value in its isolated form). It is one of the minor constituents of silymarin, the standardized extract from milk thistle (Silybum marianum) seeds, typically comprising approximately 5–10% of the total silymarin complex by weight, compared to silybin which dominates at ~50–70%. As a bioactive compound, silydianin contains a phenylchromane skeleton with multiple hydroxyl groups conferring its antioxidant capacity. Oral bioavailability of silydianin, like other flavonolignans, is generally low due to limited aqueous solubility, first-pass hepatic metabolism, and poor intestinal absorption; studies on the broader silymarin complex suggest systemic bioavailability of individual flavonolignans typically falls below 1–5% from standard formulations, with phospholipid complexes (e.g., Siliphos) improving absorption by up to 4–5 fold. No standalone pharmacokinetic data specific to isolated silydianin in humans is currently published. In commercial milk thistle extracts standardized to 70–80% silymarin, silydianin concentration is estimated at roughly 35–80 mg per 1,000 mg extract. No dietary reference intakes (DRIs) or established daily values exist for silydianin.

Preparation & Dosage

Clinically studied as part of silymarin extracts standardized to 70-80% flavolignans (silydianin comprises 10-20%). Doses range from 210mg/day (70mg t.i.d.) to 2100mg/day (700mg t.i.d.) for 8-48 weeks. Higher doses exceeding 1500mg/day have been confirmed safe. No isolated silydianin dosing data available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Silybin, Silychristin, Alpha-lipoic acid, N-acetylcysteine, Vitamin E

Safety & Interactions

Silydianin safety data is limited as it's typically consumed as part of milk thistle extracts rather than in isolation. General milk thistle safety profiles suggest mild gastrointestinal side effects may occur including nausea and diarrhea. Potential interactions with CYP450 enzymes may affect drug metabolism, though specific silydianin interactions are not well-documented. Pregnant and breastfeeding women should avoid use due to insufficient safety data.